Our Extended Family of Portfolio Companies

Investing in transformational ideas and entrepreneurial grit to solve major unmet needs in patient care

view more →

410 Medical is dedicated to developing innovative products that help emergency clinicians provide better care for critically ill patients.

view more →

Aer Therapeutics is a clinical stage biopharmaceutical company developing a novel inhaled approach to treat lung disease with excess mucus and mucus plugs.

view more →

Altis has developed a patent-pending stem cell technology recreating the human intestinal epithelium for compound screening and microbiome research.

view more →

AtaCor Medical is developing a novel extracardiac pacing system that does not require leads or hardware to be placed inside or onto the heart.

view more →

Providing in-home primary care for seniors with complex conditions, especially those with dementia

view more →

Atsena Therapeutics is a clinical-stage, ophthalmology-focused gene therapy company

view more →

Avivomed engages in developing neuromodulation therapy intended to treat unmet clinical needs.

view more →

Axonis Therapeutics is a Boston-based, neuro-focused biotechnology company developing first- and best-in-class medicines targeting KCC2.

view more →

Ed-tech platform that pairs high achieving, under-resourced students with mentors to guide them to successful career outcomes

view more →

Their clinical research software accelerates timelines by automating multiple high impact processes.

view more →

Boomerang Medical is developing a technology to advance the treatment of autoimmune diseases by using electrical nerve stimulation

view more →

(BITT) is a Boston-based biopharmaceutical company developing immune-based approaches for the treatment of cancer and infectious diseases.

view more →

Tech-enabled service designed to make caregiving easier for family caregivers

view more →

Contego Medical has developed a platform based on the integration of an embolic protection filter and a treatment device into one single catheter.

view more →

Developing first-in-class approach to activate myeloid cells to kill cancer. 

view more →

Provider of a clinical research platform intended to revolutionize the clinical research industry

view more →

Endogenex is a clinical stage company, founded to improve outcomes for people living with Type 2 Diabetes.

view more →

Developer of biologic and medical device technologies for wound management designed to improve the safety and availability of human blood supply.

view more →

GeneCentric Therapeutics is applying proprietary technology to identify drug responder populations that enable the development of precision cancer drugs.

view more →

GoCheck Kids is the leading digital vision screening platform for children. 

view more →

Gozio promotes loyalty and growth for a health system by creating a system-specific app that enhances the patient experience.

view more →

Huma.ai is a next-generation low code/no code data science solution for the life sciences industry.

view more →

IMMvention is developing novel, first-in-class therapies for treating hemolytic anemias.

view more →

iVEAcare is developing innovative neuromodulation therapy to treat unmet clinical needs impacting large patient populations.

view more →

We have developed a novel liquid biopsy assay platform which interrogates tumor-derived extracellular vesicles.

view more →

Operator of a biopharmaceutical agency intended to offer drugs for the treatment of diabetes and other metabolic disorders.

view more →

Perfuse Therapeutics, Inc. is a seed stage biotechnology company focusing on improving retinal perfusion

view more →

Developer of a molecular diagnostics technology designed to dramatically reduce time to results in microbiology.

view more →

RapidPulse, Inc. is a privately held medical device company that develops minimally invasive vascular products for ischemic stroke.

view more →

The SHAPE-MaP technology developed in the lab of Dr. Weeks identifies functional motifs within RNA by mapping the RNA three-dimensional structure.

view more →

Software and logistics solution for physicians allowing them to become independent DME suppliers

view more →

SafeRide’s technology provides end-to-end data transparency while improving patient experience, population health, and program efficiency.

view more →

Platform linking natural compounds and ethnobotanical evidence to generate novel drug candidates

view more →

Synaptrix is focused on developing and commercializing drug-free, long-lasting solutions for post-operative pain management.

view more →

Ten63 Therapeutics is focused on improving human health by developing better, more durable therapeutics against cancer and some of the world’s most lethal diseases.

view more →

Developer of novel engineered compounds designed to corneal dystrophies, improve human health and create new therapies using drugs developed with protein engineering.

view more →

Tune strives to develop paradigm-changing cell and gene therapies.

view more →

Provides analytics and software infrastructure to support the operations of social care networks, Medicaid waiver programs, and value-based care organizations

view more →

Sleep management platform built to address sleep conditions from testing through ongoing care via a wearable patch

view more →

Developer of health engagement platform intended to connect families to health resources on the smartphone.